Azomyr |
Human |
desloratadine |
desloratadine |
EMEA/H/C/000310 |
N.V. Organon |
2001/01/15
|
Authorised |
Trizivir |
Human |
abacavir (as sulfate) / lamivudine / zidovudine |
abacavir (as sulfate), lamivudine, zidovudine |
EMEA/H/C/000338 |
ViiV Healthcare BV |
2000/12/27
|
Authorised |
Luveris |
Human |
lutropin alfa |
lutropin alfa |
EMEA/H/C/000292 |
Merck Europe B.V. |
2000/11/29
|
Authorised |
NeoSpect |
Human |
depreotide |
depreotide trifluoroacetate |
EMEA/H/C/000263 |
CIS bio international |
2000/11/29
|
Withdrawn |
Porcilis AR-T DF |
Veterinary |
adjuvanted vaccine against progressive atrophic rhinitis in piglets |
protein dO (non-toxic deletion derivative of Pasteurella multocida dermonecrotic toxin), inactivated Bordetella bronchiseptica cells |
EMEA/V/C/000055 |
Intervet International BV |
2000/11/16
|
Authorised |
Pruban |
Veterinary |
resocortol butyrate |
resocortol butyrate |
EMEA/V/C/000048 |
Intervet International BV |
2000/11/16
|
Withdrawn |
Pulsaflox |
Veterinary |
difloxacin |
difloxacin |
EMEA/V/C/000060 |
Virbac S.A. |
2000/11/16
|
Withdrawn |
Infanrix Penta |
Human |
diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) vaccine (adsorbed) |
Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain)), hepatitis B surface antigen |
EMEA/H/C/000295 |
GlaxoSmithKline Biologicals S.A. |
2000/10/23
|
Withdrawn |
Infanrix Hexa |
Human |
diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type-b (Hib) conjugate vaccine (adsorbed) |
Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis B surface antigen, poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain)), Ha |
EMEA/H/C/000296 |
GlaxoSmithKline Biologicals S.A. |
2000/10/23
|
Authorised |
Hexavac |
Human |
diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted |
purified diphtheria toxoid, Purified Tetanus Toxoid, purified pertussis toxoid, purified pertussis filamentous haemagglutinin, hepatitis B surface antigen, Inactivated Type 1 Poliovirus (Mahoney), inactivated type 2 poliovirus (MEF 1), Inactivated Type 3 |
EMEA/H/C/000298 |
Sanofi Pasteur MSD, SNC |
2000/10/23
|
Withdrawn |
Agenerase |
Human |
amprenavir |
amprenavir |
EMEA/H/C/000264 |
Glaxo Group Ltd. |
2000/10/20
|
Withdrawn |
Actos |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/000285 |
CHEPLAPHARM Arzneimittel GmbH |
2000/10/13
|
Authorised |
Glustin |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/000286 |
Takeda Pharma A/S |
2000/10/11
|
Withdrawn |
Panretin |
Human |
alitretinoin |
alitretinoin |
EMEA/H/C/000279 |
Eisai GmbH |
2000/10/11
|
Withdrawn |
Keppra |
Human |
levetiracetam |
levetiracetam |
EMEA/H/C/000277 |
UCB Pharma SA |
2000/09/29
|
Authorised |
Herceptin |
Human |
trastuzumab |
trastuzumab |
EMEA/H/C/000278 |
Roche Registration GmbH |
2000/08/28
|
Authorised |
Hepacare |
Human |
hepatitis B surface antigens recombinant (S, pre-S1, pre-S2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (C127I) cells] |
hepatitis B surface antigens recombinant (S, pre-S1, pre-S2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (C127I) cells] |
EMEA/H/C/000261 |
Evans Vaccines Ltd. |
2000/08/04
|
Withdrawn |
Kogenate Bayer |
Human |
octocog alfa |
Octocog alfa |
EMEA/H/C/000275 |
Bayer AG |
2000/08/04
|
Withdrawn |
Helixate NexGen |
Human |
octocog alfa |
Octocog alfa |
EMEA/H/C/000276 |
Bayer AG |
2000/08/04
|
Withdrawn |
NovoMix |
Human |
insulin aspart |
insulin aspart |
EMEA/H/C/000308 |
Novo Nordisk A/S |
2000/08/01
|
Authorised |